HSA Adverse Drug Reaction News 2020 May, Vol.22 No.1

HSA Adverse Drug Reaction News 2020 May, Vol.22 No.1

The aim of the news bulletin is to increase the awareness of adverse events related to health products amongst healthcare professionals, and to promote adverse event reporting related to health products.

• ADR_News_May2020_Vol22_No1 [PDF, 674 KB]

This issue includes the following topics:

•  MOH’s National Drug Allergy Reporting Guidelines to reduce medication errors

• Fimasartan and local reports of liver injury

• Analysis of adverse event reports for year 2019

•  Safety update on gentian violet antiseptic

• AE Case in Focus: Test Yourself - What could have caused the development of bullous pemphigoid-like lesions on the patient’s palms and soles and macular pruritic lesions on his body trunk?

• Risk of adverse outcomes with light-exposed parenteral nutrition products when used in neonates and children below two years old